Role of chemokines, innate and adaptive immunity is a research paper published in Cellular Signalling (2020). On theSindex it has a DataRank of 0.646. It has been cited 73 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 2T32AI007051-36A1
Immunologic Diseases and Basic Immunology
National Institutes of Health
Grant: 1I01BX004232-01A2
Intra-renal T-cell heterogeneity in ADPKD patients
National Institutes of Health
Grant: 1K01DK114164-01A1
Defining the functional role of T-cells in Autosomal Dominant Polycystic Kidney Disease pathology
National Institutes of Health
Grant: 3P30DK090868-05S1
Baltimore PKD Research and Clinical Core Center
National Institutes of Health
Grant: 3P30DK074038-10S1
Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC)
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 1 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 2 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 2 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 3 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 3 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 4 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 4 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 5 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
Additional file 5 of Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion